GLYC · GlycoMimetics Inc
Acquired Company
Crescent Biopharma completed the merger with GlycoMimetics on June 16, 2025, and the combined company began trading on Nasdaq under the ticker CBIO.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of new glucomimetic drugs to address unmet medical needs resulting from disease in the United States. The company is headquartered in Rockville, Maryland.
P.O. BOX 65, MONROVIA, MD, UNITED STATES, 21770, Monrovia, MD, 21770, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
10.13M
52 Wk Range
$0.00 - $0.00
Previous Close
$0.16
Open
$15.70
Volume
N/A
Day Range
$0.16 - $15.70
Enterprise Value
4.579M
Cash
5.614B
Avg Qtr Burn
-5.106B
Insider Ownership
2.66%
Institutional Own.
47.77%
Qtr Updated
Mar 31st 2025